Items where authors include "Mellor, J."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Goyal, N.A., Bonar, K., Savic, N. et al. (4 more authors) (2024) Misdiagnosis of amyotrophic lateral sclerosis in clinical practice in Europe and the USA: a patient chart review and physician survey. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25 (1-2). pp. 16-25. ISSN 2167-8421

Mellor, J. orcid.org/0000-0003-1452-887X, Kuznetsov, D. orcid.org/0000-0002-9972-947X, Heller, S. orcid.org/0000-0002-2425-9565 et al. (15 more authors) (2024) Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia, 67 (10). pp. 2210-2224. ISSN 0012-186X

Mellor, J. orcid.org/0000-0003-1452-887X, Kuznetsov, D. orcid.org/0000-0002-9972-947X, Heller, S. orcid.org/0000-0002-2425-9565 et al. (15 more authors) (2024) Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia, 67 (8). pp. 1588-1601. ISSN 0012-186X

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Book Section

Blake, M.K., Mellor, J., Crane, L. et al. (1 more author) (2009) Eating In Time, Eating Up Time. In: Jackson, P., (ed.) Changing Families, Changing Food. Palgrave Macmillan UK , pp. 187-204. ISBN 978-0-230-24479-5

Proceedings Paper

Price, K., Mellor, J., Mcnamara, M. et al. (4 more authors) (2022) Large single-centre cohort of HSP patients in UK: advantages of deep pheno- typing and longitudinal follow-up. In: Journal of Neurology, Neurosurgery & Psychiatry. ABN Annual Meeting 2020, 07 Sep - 12 Nov 2020, Virtual, online. BMJ , A10-A10.